Additionally, in humans, genome-wide association studies have shown that patients with loss-of-function polymorphisms of genes involved in the IL-23 pathway are significantly less susceptible to developing IBD over their lifetime [1]. The gene discussed is IL23A; the disease is inflammatory bowel disease.